✦ LIBER ✦

52 COMPARISON OF MOLECULAR MARKERS, SUB-STAGE AND THE EORTC RISK-SCORE TO PREDICT CLINICAL OUTCOME OF PT1 BLADDER CANCER

✍ Scribed by B.W.G. Van Rhijn; T.H. Van Der Kwast; B. Bapat; P.J. Bostrom; N.E. Fleshner; M.N.M. Van Der Aa; L. Liu; C.H. Bangma; M.A.S. Jewett; E.C. Zwarthoff; A.R. Zlotta

Book ID: 119620797
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 83 KB
Volume: 9
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(10)60060-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1714 COMPARISON OF MOLECULAR MARKERS, SU

1714 COMPARISON OF MOLECULAR MARKERS, SUB-STAGE AND THE EORTC RISK-SCORE TO PREDICT CLINICAL OUTCOME OF PT1 BLADDER CANCER

✍ van Rhijn, Bas; van der Kwast, Theo; Bapat, Bharati; Bostrom, Peter; Fleshner, N 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

672 IMPACT OF SUB-STAGE AND PATHOLOGY RE

672 IMPACT OF SUB-STAGE AND PATHOLOGY REVIEW ON THE CLINICAL OUTCOME OF PT1 BLADDER CANCER

✍ B.W.G. Van Rhijn; T.H. Van Der Kwast; D. Kakiashvili; N.E. Fleshner; M.N.M. Van 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 507 KB

Prognostic value of molecular markers, s

Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer

✍ Bas W.G. van Rhijn; Liyang Liu; André N. Vis; Peter J. Bostrom; Tahlita C.M. Zui 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Reply to Dr Maffezzini's Letter to the E

Reply to Dr Maffezzini's Letter to the Editor re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials. Eur Urol 2006;49:466–77

✍ Richard J. Sylvester 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB